ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1415

TNF-Induced IRF1 Is Critical for the Inflammatory Gene Expression in Fibroblast-like Synoviocytes

Michael Bonelli1, Karolina von Dalwigk2, Birgit Niederreiter1, Thomas Pap3, Josef S. Smolen4, Hans Peter Kiener1 and Thomas Karonitsch1, 1Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Institute of Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 4Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Fibroblasts, Inflammation, rheumatoid arthritis (RA) and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocytes (FLS) are increasingly recognised as major pathogenic cells in synovial inflammation of patients with Rheumatoid Arthritis (RA). In response to pro-inflammatory stimuli, such as TNF, FLS produce vast amounts of cytokines and chemokines that help to recruit and activate immune cells and drive the local inflammatory process. The pathways and transcription factors that determine the inflammatory response in FLS are, however, largely unexplored. Here, we investigated the potential contribution of the transcription-factor IRF1 to the inflammatory gene expression in FLS.

Methods: Expression of IRF1 in synovial tissue samples (12 RA and 8 osteoarthritis (OA) patients) was assessed by immunohistochemistry (IHC). Moreover, FLS were isolated according to established protocols and cultured using 2-D or 3-D culture techniques. IRF1expression in response to TNF was determined by western blots, qPCR, immunofluorescence microscopy or IHC. FLS were also stimulated with TNF in the presence or absence of IRF1 siRNA pools. Expression of pro-inflammatory cytokines and chemokines was measured by qPCR.

Results: IRF1 expression was significantly increased in rheumatoid synovial tissues as compared to patients with OA on protein level. RA-FLS stimulation with TNF ex vivo caused rapid upregulation of IRF1 and proved the involvement of TNF in the regulation of IRF1. Immunoflourescence analysis further revealed that IRF1 was mainly localized in the nucleus of TNF-stimulated FLS. Moreover, also chronic TNF exposure of FLS grown in a 3-D synovial tissue culture system promoted the expression of IRF1. SiRNA-mediated knockdown of IRF1 in FLS significantly reduced the TNF-induced expression of pro-inflammatory cytokines and chemokines, such as IL6, CCL7, CXCL11 and TNFSF13B, which confirmed the role of IRF1 as a critical regulator of proinflammatory genes in RA FLS.

Conclusion: Our data reveal that IRF1 is crucial for the inflammatory response of FLS and support the idea that IRF1 might be an exciting therapeutic target in patients with RA.


Disclosure: M. Bonelli, None; K. von Dalwigk, None; B. Niederreiter, None; T. Pap, Orthogen, 5; J. S. Smolen, AbbVie, Eli Lilly, Janssen, MSD, Pfizer Inc, Roche, 2,AbbVie, Amgen, AstraZeneca, Astro, Celgene, Celtrion, Eli Lilly, GSK, ILTOO, Janssen, MedImmune, MSD, Novartis-Sandoz, Pfizer Inc, Roche, Samsung, Sanofi, UCB, 5,AbbVie, Amgen, AstraZeneca, Astro, Celgene, Celtrion, Eli Lilly, GSK, ILTOO, Janssen, MedImmune, MSD, Novartis-Sandoz, Pfizer Inc, Roche, Samsung, Sanofi, UCB, 8; H. P. Kiener, None; T. Karonitsch, None.

To cite this abstract in AMA style:

Bonelli M, von Dalwigk K, Niederreiter B, Pap T, Smolen JS, Kiener HP, Karonitsch T. TNF-Induced IRF1 Is Critical for the Inflammatory Gene Expression in Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/tnf-induced-irf1-is-critical-for-the-inflammatory-gene-expression-in-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tnf-induced-irf1-is-critical-for-the-inflammatory-gene-expression-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology